An Act establishing a transferable pediatric cancer research tax credit
Massachusetts bill creates transferable tax credits for pediatric cancer research funding, allowing businesses to sell unused credits for increased investment incentives.
Massachusetts bill creates transferable tax credits for pediatric cancer research funding, allowing businesses to sell unused credits for increased investment incentives.
H 3269 establishes a transferable tax credit in Massachusetts for businesses and individuals who fund pediatric cancer research. The credit can be transferred to other taxpayers if unused, increasing its flexibility and market value. This mechanism aims to incentivize private investment in pediatric cancer research by making the tax benefit more liquid and valuable.
Pediatric cancer research is chronically underfunded relative to adult cancers, despite affecting children's survival and quality of life. By creating financial incentives for private research investment, the bill could accelerate drug development and clinical trials. The transferability feature makes the credit more attractive to investors, potentially generating more research funding than traditional, non-transferable credits.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.